For the Inventor, By the Inventor

Enter assignee name

Irvine, CA, United States of America

Chromadex Inc.

USPTO Granted Patents = 21

CIPO Patents = 15

EPO Patents = 5

Trademarks = 32

Forward Citations = 50

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Marie Eugenie Migaud (11 out of 18 patents)

Philip Redpath (10 out of 15 patents)

Richard Cunningham (10 out of 10 patents)

4. Aron Erickson (10 out of 10 patents)

5. Troy Rhonemus (10 out of 10 patents)

6. Ryan Dellinger (9 out of 18 patents)

7. Kerri Crossey (9 out of 14 patents)

8. Amanda Storjohann (9 out of 9 patents)

9. Richard Nygaard (7 out of 10 patents)

10. Mark Morris (4 out of 12 patents)

11. Amy Boileau (3 out of 3 patents)

12. Dietrich Conze (3 out of 3 patents)

13. Ann Deren-Lewis (2 out of 2 patents)

14. Sylesh Venkataraman (2 out of 2 patents)

15. Brian Nettles (2 out of 2 patents)

21 patents: Sort by Forward Citations

1. 12485134 - Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations (2025-12-02),

2. 12433908 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2025-10-07),

3. 12195494 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2025-01-14),

4. 11746123 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2023-09-05),

5. 11524022 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2022-12-13),

6. 11345720 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2022-05-31),

7. 11274117 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2022-03-15),

8. 11242364 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2022-02-08),

9. 11214589 - Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof (2022-01-04),

10. 11033568 - Nicotinamide riboside compositions for topical use in treating skin conditions (2021-06-15),

11. 10934322 - B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof (2021-03-02),

12. 10857172 - Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development (2020-12-08),

13. 10689411 - Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof (2020-06-23),

14. 10688118 - Nicotinamide riboside compositions for topical use in treating skin conditions (2020-06-23),

15. 10280190 - Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions (2019-05-07),

ChromaDex Inc. is a science-based integrated nutraceutical company that discovers, develops, and commercializes patented and proprietary ingredients. The company offers a wide range of quality ingredients and finished products that promote health, wellness, and longevity. ChromaDex's focus areas include cellular health, cognition, cardiovascular health, energy, and aging. With a commitment to scientific rigor and innovation, ChromaDex aims to deliver trusted solutions that customers can rely on for their well-being.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

21 Patents

#157 in Irvine, CA

#3,615 in California

#15,151 in US

#29,031 in the World

Irvine, CA, United States of America

Chromadex Inc.

Forward Citations = 50

31 inventors:

Marie Eugenie Migaud (11 out of 18 patents)

Philip Redpath (10 out of 15 patents)

Richard Cunningham (10 out of 10 patents)

4. Aron Erickson (10 out of 10 patents)

5. Troy Rhonemus (10 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…